What changed 10-Q

Item 5. Other Information

2024-05-20 compared with 2023-11-13 · 3 added, 1 removed, 15 unchanged (21% of the section changed)

OTHER INFORMATION

the quarter ended March 31, 2024, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading

arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation

Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 *

8 unchanged sentences

to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by

the undersigned thereunto duly authorized, on November 13, 2023.

the undersigned thereunto duly authorized, on May 20, 2024.

SUNSHINE BIOPHARMA, INC.

3 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.